Zantac Manufacturers - Legal Claims for Cancer Caused by Zantac

Available via prescription, as well as over the counter, Zantac has long been recommended by doctors for treating heartburn, acid reflux, and ulcers of the stomach. The drug came into commercial use in 1981 and it was the fourth most commonly prescribed medication in the United States, before the FDA has requested all ranitidine and Zantac products be pulled from shelves as part of a nationwide, voluntary recall.

A Zantac claim is a legal action that allows consumers who purchased prescription Zantac or/and generic ranitidine to recover financial compensation for medical care, time away from work, and the ongoing expenses this drug has caused them to incur. In the case of death, family members may also be eligible for compensation available to cover the costs related to a victim's funeral and burial, loss of expected earnings, and loss of companionship.

Manufacturers Have Issued Voluntary Recalls of Certain Lots of Zantac Found to Contain Trace Amounts of NDMA a Known Carcinogen

The FDA has issued an urgent order requesting manufacturers to withdraw all prescription and over-the-counter ranitidine drugs from the market immediately, saying that potential NDMA contamination may place patients at risk of developing certain cancers.

To date, several ranitidine products have been either recalled or removed from warehouses and pharmacies' shelves. The companies that have recalled their ranitidine products include:

• American Health Packaging
• Amneal Pharmaceuticals, LLC
• Apotex Corp.
• Appco Pharma LLC
• Aurobindo Pharma USA
• Denton Pharma, Inc.
• Dr. Reddy's Laboratories Ltd.
• Glenmark Pharmaceutical Inc.
• Golden State Medical Supply
• Lannett Company, Inc.
• Novitium Pharma
• Northwind Pharmaceuticals
• Novartis
• Perrigo
• PrecisionDose
• Sandoz Inc.
• Sanofi
• Walmart

Ranitidine Users With NDMA-Related Cancer Have the Right to File a Claim and Receive Financial Compensation

The first lawsuits were filed after the online pharmacy Valisure, which tests prescription drugs before dispensing them, notified the FDA that it had detected "extremely high levels" of NDMA - classified as a probable human carcinogen - in "every lot tested, across multiple manufacturers" of ranitidine products, including Zantac.

The lawsuits are arguing that Zantac's manufacturers knew Zantac could convert to NDMA in the body once it's swallowed, yet failed to warn users about the serious health risks - including cancer - that came with taking the heartburn drug.

The main manufacturers include Sanofi-Aventis, Boehringer Ingelheim, and GSK. The drugmakers allegedly:

• manufactured, marketed, and distributed a defectively designed medication
• failed to warn physicians and consumers about the potential health risks

Have You or a Loved One Been Affected by Zantac? We Can Help You Learn About Your Legal Rights

If you or a loved one has taken Zantac and been diagnosed with cancer, you may be entitled to compensation for medical bills, lost wages, and pain and suffering. The first big step is talking with you to learn the facts and to let you know if you are in a position to seek compensation.

If you are eligible to make a compensation claim, our experienced case managers can help you:

• provide quality assistance
• collect relevant evidence that may be needed to protect your claim for appropriate financial compensation
• promptly connect you with the most suitable professionals in your area

Call us today to schedule a free initial consultation with our experienced and knowledgeable team of experts.